Siddharth Mittal
business executiveMale0.0Global Dominance: 0.00%
Siddharth Mittal is the CEO of Biocon, a leading biopharmaceutical company in India. Under his leadership, Biocon is preparing to launch injectable weight-loss products, including semaglutide, in 2027, with plans for international exports to countries like Brazil and Canada.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Siddharth Mittal is the CEO of Biocon, which is investing in an injectables facility in Bengaluru.
Is India about to make Ozempic-like weight-loss drugs a whole lot cheaper?CNN·
United States· 2026-02-08
United States· 2026-02-08
